Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Biotech Stocks Facing FDA Decision In October 2023

Por: RTTNews Health October 05, 2023

thumbnail

As we step into the year's last quarter, it is worth noting that the FDA has already granted approval to 40 novel drugs in 2023, a significant increase compared to the 26 novel drugs approved during the same period last year.Now, let's turn our attention to the drugs awaiting the For comments and feedback contact: [email protected]... + full article



Similar News

Biotech Stocks Facing FDA Decision In June 2023

RTTNews USA Health May 27, 2023

thumbnailAs we step into the third month of the second quarter, let's take a quick look at the regulatory news that made headlines in May and offer you a sneak peek into the anticipated FDA decisions coming up in June.On May 1, the FDA conditionally approved Elanco's... + más

Daydream Believers: Read This Before You Invest In AI | Forbes

US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns | Fox Business


US health system will go 'bankrupt' in 'a few years,' biotech entrepreneur warns

Fox Business USA Tech April 06, 2023

thumbnailGraviton Chairman and CEO Sam Waksal joined ‘Mornings with Maria’ to discuss the recent ‘implosion’ in the biotech sector and the country's latest efforts to fuel Alzheimer’s research. One biotech leader is sounding the alarm on a dire problem faced by the health... + más

Did Martha Washington really name a cat after Alexander Hamilton? | The Boston Globe

'Frustration' fuels Broncos' sideline blowup in loss | ESPN


Daydream Believers: Read This Before You Invest In AI

Forbes USA Business March 04, 2023

thumbnailAI is going from red hot to white hot. Is that hot enough to burn investors? Pitchbook notes that venture capital investment in generative AI like ChatGPT is up 425% since 2020, from $500 million to more than $2.1 billion. The global VC industry is plunked into AI. Roughly 40%... + más

What 'Moonage Daydream' Teaches Us About David Bowie | Time

‘Moonage Daydream’ celebrates David Bowie and his many ch-ch-ch-ch-changes | The Boston Globe


Boston biotech internship program aims to increase diversity through expansion

The Boston Globe USA Business February 06, 2023

thumbnailWhen Betelihem Alemayehu moved with her parents from the countryside of Ethiopia to Boston nearly a decade ago, she didn’t know how to ride the T, she couldn’t speak English, and she could never have guessed that one day she’d be employed in one of the city’s... + más

Wall Street internship checklist: How to land a competitive 2024 summer job in investment banking, trading, or asset management | Business Insider

‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year. | The Boston Globe


‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year.

The Boston Globe USA Business January 21, 2023

thumbnailIt’s hard to overstate the Boston biotechnology industry’s astronomical growth, which has overflowed from its longtime stronghold of Kendall Square in Cambridge into the Fenway, Seaport, and surrounding suburbs. But by most financial measures, 2022 was a terrible, horrible,... + más

NFL Week 4: Across the league, teams have hit the ground running this year | The Boston Globe

Boston biotech internship program aims to increase diversity through expansion | The Boston Globe


Why biotech is poised for a recovery this year

Fox Business USA Business January 17, 2023

thumbnailRep. Darrell Issa, R-Calif., discusses Biden's classified documents debacle, the latest 'Twitter File' that highlights the pharmaceutical industry's role in vaccine content, the U.S. debt ceiling and China's economy. The drug industry is now divided... + más

‘Holding on by its fingernails.’ The biotech industry in Massachusetts braces for another tough year. | The Boston Globe

Boston biotech internship program aims to increase diversity through expansion | The Boston Globe


What we know about the new COVID-19 variant XBB

The Boston Globe USA Nation December 29, 2022

thumbnailA new coronavirus variant dubbed XBB has swiftly spreading in the Northeast, jumping from about 35 percent of cases during the week ending Dec. 17 to just over half of cases last week, according to .Here’s a quick primer on what we know about the variant.It is more... + más

Highly Immune Evasive Omicron XBB.1.5 Variant Is Quickly Becoming Dominant in U.S. as It Doubles Weekly | NBC 6 South Florida

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly | CNBC



About iurex | Privacy Policy | Disclaimer |